Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04130269

Anxiety, Stress and Pain & Myocardial Infarction

The Impact of Anxiety, Stress and Pain in the Early Phase of Myocardial Infarction on the Development of Anxiety Symptoms and Posttraumatic Stress Disorder in the Long Term Outcome

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
19 Years – 90 Years
Healthy volunteers
Accepted

Summary

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing Posttraumatic Stress Disorder (PTSD) after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress, and PTSD after an acute myocardial infarction.

Detailed description

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing PTSD after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress and PTSD after an acute myocardial infarction. Patients will be examined during three times - in the acute myocardial infarction period (Day 1-3), before dismissal (Day 5-14) and after 6 months for a follow-up. During all times they will be given questionnaires asking about their levels of stress, anxiety and general well-being as well as tests checking their cognitive abilities (thus to find out if they decrease over time). Moreover, blood samples checking cortisol levels as well as metanephrine levels will be taken in order to objectify the levels of stress that are stated by the patients. Furthermore, clinical evaluations, laboratory runs (troponin), ECGs and echocardiographies will be done at all three points in time. The goal is to detect the biopsychosocial relations and to develop better prevention.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionQuestionnaires, lab-run

Timeline

Start date
2020-04-07
Primary completion
2027-12-07
Completion
2027-12-07
First posted
2019-10-17
Last updated
2025-09-29

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04130269. Inclusion in this directory is not an endorsement.